Ownership history in Bayesian Capital Management, LP · 10 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in LABORATORY CORP AMER HLDGS (LH). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | ADDED | 7,300 | +2,100 | +40.4% | 0.43% | $2.1M | $285.58 |
| 2022 Q3 | REDUCED | 5,200 | -2,000 | -27.8% | 0.22% | $1.1M | $168.62 |
| 2022 Q2 | ADDED | 7,200 | +5,800 | +414.3% | 0.31% | $1.7M | $192.41 |
| 2022 Q1 | ADDED | 1,400 | +626 | +80.9% | 0.06% | $369K | $215.84 |
| 2021 Q4 | REDUCED | 774 | -1,026 | -57.0% | 0.08% | $243K | $257.22 |
| 2021 Q3 | ADDED | 1,800 | +734 | +68.9% | 0.15% | $507K | $230.40 |
| 2021 Q1 | REDUCED | 1,066 | -1,434 | -57.4% | 0.06% | $272K | $208.78 |
| 2019 Q1 | REDUCED | 2,500 | -12,200 | -83.0% | 0.07% | $382K | $125.24 |
| 2017 Q3 | ADDED | 14,700 | +10,064 | +217.1% | 0.53% | $2.2M | $123.59 |
| 2016 Q2 | INITIATED | 4,636 | — | — | 0.36% | $604K | $106.64 |
As of 2025 Q4 — sorted by position size